Kirsten Craven

Selecting an LC-MS system for quantitation of pharmaceutical drug development

Oct 29, 2024 | Blogs, Echo MS, Pharma, QTRAP / Triple Quad, ZenoTOF 7600 system | 0 comments

Read time: 2 minutes

Introduction

Drug development is a challenging process that requires diverse analytical solutions and the expertise of research scientists.

Within drug discovery confident go/no-go decisions need to be made as quickly as possible. Often, highly sensitive techniques are needed to accurately monitor concentrations of biomarkers, therapeutic candidates, and their metabolites. QA/QC laboratories need consistent performance everyday over many years.

Pharmaceutical quantitation solution guide

We understand you are busy, needing to prioritize running instruments, reporting results and managing your laboratory to meet deadlines. We created a solution guide to explain how SCIEX systems fit in the drug development pipeline to save you time evaluating options.

The guide covers bio/pharmaceutical quantitative assays from discovery to QA/QC, for large and small molecules. Discussing challenges regularly faced by scientists, along with potential solutions.

Download the guide >

What’s inside the guide?

The guide includes comprehensive chapters addressing multiple challenges and solutions regularly faced in drug development.

Discovery

Identify hits with accuracy and speed
Easily report results with end-to-end workflows
Measure molecular masses for small and large drug candidates

Development (Small and large molecules)

Acquire reliable and sensitive bioanalytical data
Perform studies with confidence using compliance-ready software
Get support from a team of dependable experts

Regulatory solutions

Minimize regulatory risk with complete system solutions
Ensure compliance for instruments through installation and maintenance qualifications
Reduce human error with user access levels

QA/QC and lot release

Quickly identify deviations from product specifications
Flexible system configurations that can be tailored to an ever-evolving regulatory landscape
Expert application and service support

Products

Discover systems at the forefront of quantitative performance
Benefit from compliance-ready software and trusted service partners
Ensure your results are the best they can be

Download the guide here >

PFAS testing: 2024 in review and what to expect for 2025

For as long as PFAS persist in the environment, there is no doubt they will persist in our conversations as environmental scientists. Globally, PFAS contamination has been detected in water supplies, soil and even in the blood of people and wildlife. Different countries are at various stages of addressing PFAS contamination and many governments have set regulatory limits and are working on assessing the extent of contamination, cleaning up affected sites and researching safer alternatives.

Inside the box: Acoustic ejection mass spectrometry for drug discovery

On average, it takes 10-15 years and 1-2 billion dollars to approve a new pharmaceutical for clinical use. Since approximately 90% of new drug candidates fail in clinical development, the ability to make early, informed and accurate decisions on the safety and efficacy of new hits and leads is key to increasing the chances of success.

Unveiling the power of ZT Scan DIA: Insights from Ludwig Sinn’s presentation at World HUPO Congress 2024

In a recent presentation at the World HUPO Congress 2024, Ludwig Sinn from the Ralser lab shared exciting advancements in proteomics research, focusing on the innovative ZT Scan DIA acquisition modes developed in collaboration with SCIEX. Let us explore the key highlights and benefits of this innovative technology.

Posted by

Kirsten Craven

Kirsten Craven is the Senior Global Marketing Manager for Pharma global strategic marketing at SCIEX. In this role, she manages strategic marketing for the pharmaceutical industry. Kirsten spent the first part of her career working in laboratories across multiple industries before moving into product management, and most recently pharma marketing.

0 Comments